ANDA 40515, held by Am Regent. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 40515 (Promethazine Hydrochloride), held by Am Regent, was first approved by FDA on Mar 19, 2003, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 19, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride25MG/ML ยท injectable;injection | Promethazine Hydrochloride | Discontinued |
| Nov 19, 2009 | Supplement 7Labeling | Approved | None posted |
| Mar 13, 2006 | Supplement 3Labeling | Approved | None posted |
| Jun 21, 2005 | Supplement 2Labeling | Approved | None posted |
| Mar 19, 2003 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters